Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: A role for scintigraphy with 99mTc-infliximab

Arthritis and Rheumatism

Volumn 52, Issue 4, 2005, Pages 1224-1226

  Conti, Fabrizio ^a   Priori, Roberta ^a   Chimenti, Maria Sole ^a   Coari, Giulio ^a   Annovazzi, Alessio ^a   Valesini, Guido ^a   Signore, Alberto ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; ROFECOXIB; SALAZOSULFAPYRIDINE;

ADULT; ARTHROCENTESIS; ARTICLE; CASE REPORT; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFORMED CONSENT; KNEE ARTHRITIS; MALE; MONARTHRITIS; PRIORITY JOURNAL; REMISSION; SCINTIGRAPHY; SPINAL PAIN; SPONDYLARTHRITIS; SYNOVIAL FLUID; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; RADIONUCLIDE IMAGING; SPONDYLITIS, ANKYLOSING; TECHNETIUM; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17244371046     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20979     Document Type: Article

References (13)

1. Neidel J, Schulze M, Lindschau J. Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor α in the knee-joints of patients with rheumatoid arthritis. Inflamm Res 1995;44:217-21.
2. Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen JS. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid. J Rheumatol 1998;25:105-10.
3. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-TNFα monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932-9.
4. Gladman DD. Effectiveness of psoriatic arthritis therapies. Semin Arthritis Rheum 2003;33:29-37.
5. Braun J, Brandt J, Listing J, Zink A, Alten R, Golden W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
6. Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-α monoclonal antibody infliximab. J Rheumatol 2002;29:118-22.
7. Van den Bosch F, Kruithof E, de Vos M, de Keyser F, Mielants H. Crohn's disease associated with spondyloarthropathy: effect of TNF-α blockade with infliximab on articular symptoms. Lancet 2000;356:1821-2.
8. Nikas NS, Temekonidis TI, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA. Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rheum Dis 2004;63:102-3.
9. Dreher R, Flaig W, Leitzeke D. Treatment of rheumatoid arthritis by intra-articular injections with TNF α blockers [abstract]. Arthritis Rheum 2001;44 Suppl 9:S42.
10. Kellner H, Kroetz M, Schattenkirchner M, Kellner W. Successful therapy of sacroileitis in AS patients by intraarticular injection of infliximab [abstract]. Arthritis Rheum 2002;46 Suppl 9:S431.
11. Andonopoulos AP, Meimaris N, Daossis D, Bounas A, Yiannopoulos G. Intraarticular anti-tumor necrosis factor α antibody in recalcitrant arthritis of Behcet's disease. Clin Exp Rheumatol 2003;21 Suppl 30:S57-8.
12. 99mTc: in vitro studies [abstract]. Q J Nucl Med 2002;46 Suppl 1:27.
13. Bokarewa M, Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 2003;62:783-4.